(Q33372268)

26 July 2017

Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer (English)

1 reference

26 July 2017

1 reference

1 reference

2

A James O'Malley

1 reference

26 July 2017

Michael J Hassett

1

1 reference

26 July 2017

Juliana R Pakes

series ordinal

3

1 reference

26 July 2017

Joseph P Newhouse

series ordinal

4

1 reference

26 July 2017

Craig C Earle

series ordinal

5

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Journal of the National Cancer Institute

26 July 2017

1 reference

26 July 2017

98

1 reference

26 July 2017

16

1 reference

26 July 2017

1108-1117

1 reference

Adverse drug reactions: definitions, diagnosis, and management

26 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

External validity of randomised controlled trials: "to whom do the results of this trial apply?".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Side effects of adjuvant treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Development of a comorbidity index using physician claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Invited commentary: propensity scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Never too old? Age should not be a barrier to enrollment in cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Threats to applicability of randomised trials: exclusions and selective participation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Enrollment of African Americans onto clinical treatment trials: study design barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

The impact of socioeconomic status and race on trial participation for older women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Protocol allocation and exclusion in two Danish randomised trials in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Centralised treatment, entry to trials and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ305

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ305

1 reference

26 July 2017

1 reference